| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8315166 | Clinica Chimica Acta | 2012 | 5 Pages |
Abstract
⺠Treatment with clopidogrel can prevent recurrent ischaemic events. ⺠Clopidorel response was associated with risk for recurrent cardiovascular events. ⺠ABCB1 and ABCC3 can limit intestinal absorption. ⺠Low ABCC3 expression had higher probability to have a good response to clopidogrel. ⺠ABCC3 mRNA expression can be contributed with increase responses to clopidogrel.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
André Ducati Luchessi, Vivian Nogueira Silbiger, Alvaro Cerda, Rosario Dominguez Crespo Hirata, Angel Carracedo, Maria Brion, Andres Iñiguez, Marisol Bravo, Guillermo Bastos, Amanda Guerra Morais Rego Sousa, Mario Hiroyuki Hirata,